Experiences with real-world teclistamab administration in community and outpatient settings: a mixed-methods study of hematology providers

Outpatient teclistamab SUD has been successfully implemented in real-world practice for appropriately selected patients. This study provides insights into real-world outpatient SUD, including in community practices, to inform providers seeking to implement similar models to improve patient access while reducing cost and resource burden.